MarcIDiamondMD

Summary

• Marc Diamond, M.D., is the founding director of the Center for Alzheimer's and Neurodegenerative Diseases (CAND). The CAND is a multidisciplinary translational research program comprised of 11 faculty members who are focused on fundamental disease mechanisms. Its mission is to develop more effective diagnosis and therapy for Alzheimer's and related disorders.
  
  Marc's original discoveries linked common conditions such as Alzheimer's to rare infectious prion disorders such as Creutzfeldt-Jakob and "mad cow" disease. His lab determined that abnormal assemblies of the tau protein move between cells and serve as templates for their own replication, and has elucidated the mechanisms of this process. This has transformed our understanding of how different neurodegenerative diseases arise and why they progress. His ideas underlie new treatment strategies currently being pursued by the pharmaceutical industry, and his methods are employed worldwide for neurodegenerative diseases research.
  
  Marc studied history at Princeton, and received his M.D. (1993) at UCSF, where he then completed residency training in Neurology in 1997, serving as chief resident in his final year. At UCSF he worked with Keith Yamamoto, Ph.D. as a Howard Hughes Medical Student Research Fellow (1989-1991) and as a postdoctoral fellow (1997-2001). He was a faculty member in the Department of Neurology at UCSF from 2002-2009, before moving to Washington University in St. Louis in 2009 as the David Clayson Professor of Neurology. Since 2014, he has been a professor of Neurology and Neuroscience at UT Southwestern Medical Center.
  
  Marc is an internationally recognized expert in neurodegenerative disease, and lectures frequently at major universities and scientific meetings around the world. His research has been cited thousands of times by his scientific colleagues.